Efficacy and safety of GST-HG171 in adult patients with mild to moderate COVID-19: a randomised, double-blind, placebo-controlled phase 2/3 trialHongzhou Lu, Nanshan Zhong, John Mao et al.|EClinicalMedicine|2024Cited by 23